» Articles » PMID: 17475894

A New Population of Cells Lacking Expression of CD27 Represents a Notable Component of the B Cell Memory Compartment in Systemic Lupus Erythematosus

Overview
Journal J Immunol
Date 2007 May 4
PMID 17475894
Citations 289
Authors
Affiliations
Soon will be listed here.
Abstract

Human memory B cells comprise isotype-switched and nonswitched cells with both subsets displaying somatic hypermutation. In addition to somatic hypermutation, CD27 expression has also been considered a universal memory B cell marker. We describe a new population of memory B cells containing isotype-switched (IgG and IgA) and IgM-only cells and lacking expression of CD27 and IgD. These cells are present in peripheral blood and tonsils of healthy subjects and display a degree of hypermutation comparable to CD27+ nonswitched memory cells. As conventional memory cells, they proliferate in response to CpG DNA and fail to extrude rhodamine. In contrast to other recently described CD27-negative (CD27neg) memory B cells, they lack expression of FcRH4 and recirculate in the peripheral blood. Although CD27neg memory cells are relatively scarce in healthy subjects, they are substantially increased in systemic lupus erythematosus (SLE) patients in whom they frequently represent a large fraction of all memory B cells. Yet, their frequency is normal in patients with rheumatoid arthritis or chronic hepatitis C. In SLE, an increased frequency of CD27neg memory cells is significantly associated with higher disease activity index, a history of nephritis, and disease-specific autoantibodies (anti-dsDNA, anti-Smith (Sm), anti-ribonucleoprotein (RNP), and 9G4). These findings enhance our understanding of the B cell diversification pathways and provide mechanistic insight into the immunopathogenesis of SLE.

Citing Articles

Skin Deep and Beyond: Unravelling B Cell Extracellular Matrix Interactions in Cutaneous Immunity and Disease.

Diehl R, Hubner S, Lehr S, Rizzi M, Eyerich K, Nystrom A Exp Dermatol. 2025; 34(3):e70068.

PMID: 40051023 PMC: 11885703. DOI: 10.1111/exd.70068.


CD38 deficiency leads to a defective short-lived transcriptomic response to chronic graft-versus-host disease induction, involving purinergic signaling-related genes and distinct transcriptomic signatures associated with lupus.

Zubiaur M, Terron-Camero L, Gordillo-Gonzalez F, Andres-Leon E, Barroso-Del Jesus A, Canet-Antequera L Front Immunol. 2025; 16:1441981.

PMID: 39995666 PMC: 11847871. DOI: 10.3389/fimmu.2025.1441981.


Deep profiling of B cells responding to various pathogens uncovers compartments in IgG memory B cell and antibody-secreting lineages.

Claireaux M, Elias G, Kerster G, Kuijper L, Duurland M, Paul A Sci Adv. 2025; 11(8):eado1331.

PMID: 39970201 PMC: 11837990. DOI: 10.1126/sciadv.ado1331.


Long-term safety and efficacy of the combination of belimumab and rituximab in the treatment of severe and refractory SLE: a preliminary report.

van Schaik M, Arends E, Wetzels M, Kraaij T, Verbruggen S, van der Kooij S Lupus Sci Med. 2025; 12(1).

PMID: 39939125 PMC: 11822420. DOI: 10.1136/lupus-2024-001424.


Know Your ABCs: Discovery, Differentiation, and Targeting of T-Bet+ B Cells.

Winslow G, Levack R Immunol Rev. 2025; 330(1):e13440.

PMID: 39844597 PMC: 11754996. DOI: 10.1111/imr.13440.